Stockscreener 앱 받기
39.72
0.18%
0.07
전일 마감가:
$39.65
열려 있는:
$39.25
하루 거래량:
425.36K
Relative Volume:
0.88
시가총액:
$1.83B
수익:
$1.08B
순이익/손실:
$-20.76M
주가수익비율:
-86.35
EPS:
-0.46
순현금흐름:
$151.63M
1주 성능:
+0.28%
1개월 성능:
-7.43%
6개월 성능:
-8.65%
1년 성능:
+45.55%
1일 변동 폭
$39.25
$40.05
1주일 범위
$38.80
$40.50
52주 변동 폭
$25.12
$55.74
옴니셀 Stock (OMCL) Company Profile
명칭
Omnicell Inc
전화
(877) 415-9990
주소
4220 NORTH FREEWAY, FORT WORTH
OMCL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
39.72 | 1.83B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
225.79 | 36.66B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
72.37 | 13.58B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.02 | 12.61B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
68.09 | 10.72B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
108.60 | 9.41B | 1.15B | 96.70M | -161.99M | 1.09 |
옴니셀 Stock (OMCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 개시 | Barclays | Underweight |
| 2023-11-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 재확인 | Wells Fargo | Underweight |
| 2023-08-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-11-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 개시 | BofA Securities | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Mkt Perform |
| 2021-12-06 | 재개 | Wells Fargo | Overweight |
| 2021-06-09 | 개시 | JP Morgan | Neutral |
| 2021-05-24 | 개시 | BTIG Research | Buy |
| 2021-02-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-12-03 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-02-07 | 재확인 | Dougherty & Company | Buy |
| 2019-11-21 | 재확인 | Dougherty & Company | Buy |
| 2019-07-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-03-07 | 재확인 | Dougherty & Company | Buy |
| 2018-06-29 | 재개 | The Benchmark Company | Buy |
| 2017-09-05 | 재확인 | The Benchmark Company | Buy |
| 2017-07-28 | 재확인 | Dougherty & Company | Buy |
| 2017-04-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 개시 | Dougherty & Company | Buy |
| 2016-12-06 | 재확인 | The Benchmark Company | Buy |
| 2016-07-07 | 재확인 | FBR Capital | Outperform |
| 2016-03-21 | 재확인 | Topeka Capital Markets | Buy |
| 2016-01-07 | 개시 | The Benchmark Company | Buy |
| 2015-11-16 | 재확인 | Topeka Capital Markets | Buy |
| 2015-10-30 | 재확인 | FBR Capital | Outperform |
| 2015-09-28 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-07-31 | 재확인 | Topeka Capital Markets | Buy |
모두보기
옴니셀 주식(OMCL)의 최신 뉴스
Omnicell (OMCL) Introduces Central Med Automation Service - MSN
Martin & Co. Inc. TN Sells 10,302 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Empowered Funds LLC Makes New $388,000 Investment in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
Medication Management System Market Future Business - openPR
Rice Hall James & Associates LLC Raises Stock Holdings in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles - MSN
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles By Investing.com - Investing.com Nigeria
Central Fill Pharmacy Automation Market Poised for Booming - openPR
Global Automated Dispensing Systems Market Size, Share, - openPR
Shaker Investments LLC OH Invests $550,000 in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires 699,925 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Why Omnicell's (NASDAQ:OMCL) Earnings Are Better Than They Seem - Simply Wall St
Omnicell's (NASDAQ:OMCL) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
IBD Rating Upgrades: Omnicell Shows Improved Technical Strength - MSN
Wall Street Analysts Think Omnicell (OMCL) Could Surge 29.03%: Read This Before Placing a Bet - MSN
Omnicell Q4 Earnings: Ignore The Short Term Noise (NASDAQ:OMCL) - Seeking Alpha
Exponential Growth Expected for Automated IV Pharmacy - openPR
Omnicell’s Earnings Call Highlights Growth Amid Challenges - TipRanks
Omnicell (NASDAQ:OMCL) Shares Gap Down After Earnings Miss - MarketBeat
Omnicell Q4 Earnings & Revenues Beat, Stock Up, Gross Margin Rises - Yahoo Finance
Omnicell (NASDAQ:OMCL) Issues FY 2025 Earnings Guidance - MarketBeat
Results: Omnicell, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Simply Wall St
Omnicell, Inc. Just Beat EPS By 47%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Omnicell (NASDAQ:OMCL) Releases Q1 2025 Earnings Guidance - MarketBeat
Omnicell's (OMCL) Buy Rating Reaffirmed at Benchmark - MarketBeat
Omnicell projects $1.105M to $1.155M revenue growth in 2025 with XT Amplify momentum - MSN
Omnicell (NASDAQ:OMCL) Issues Quarterly Earnings Results, Misses Estimates By $0.12 EPS - MarketBeat
Omnicell (OMCL) Tops Q4 Earnings and Revenue Estimates - MSN
Omnicell, Inc. (NASDAQ:OMCL) Q4 2024 Earnings Call Transcript - Insider Monkey
Omnicell (NASDAQ:OMCL) Could Be Struggling To Allocate Capital - Yahoo Finance
Omnicell Inc (OMCL) Q4 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Omnicell Inc (OMCL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Omnicell Inc (OMCL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Omnicell Reports Strong Q4 2024 Financial Results - TipRanks
Omnicell: Q4 Earnings Snapshot - Danbury News Times
Omnicell Q4 earnings beat, but stock falls on weak guidance - MSN
Omnicell earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Omnicell Inc (OMCL) Q4 2024 Earnings: EPS of $0.34 Beats Estimat - GuruFocus.com
Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations By Stock Story - Investing.com Canada
Omnicell: Q4 Earnings Snapshot -February 06, 2025 at 07:11 am EST - Marketscreener.com
Omnicell Reports Q4 2024 Non-GAAP Net Income Of $28 Million Or $0.60 Per Share - Marketscreener.com
Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations - Yahoo Finance
옴니셀 (OMCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
9.30%
2.95%
자본화:
|
볼륨(24시간):